We are live on ! Find out more
RCM

Raleigh Capital Management Portfolio holdings

AUM $313M
1-Year Est. Return 23.55%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+23.55%
3 Year Est. Return
+71.82%
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
+$21.2M
Cap. Flow
+$5.43M
Cap. Flow %
2.82%
Top 10 Hldgs %
19.8%
Holding
915
New
76
Increased
369
Reduced
163
Closed
149

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.01M
2
CVX icon
Chevron
CVX
+$861K
3
XOM icon
ExxonMobil
XOM
+$817K
4
BMY icon
Bristol-Myers Squibb
BMY
+$696K
5
MRK icon
Merck
MRK
+$685K

Sector Composition

Rank Sector Weight
1 Financials 10.54%
2 Healthcare 10.29%
3 Consumer Staples 9.47%
4 Energy 7.21%
5 Utilities 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIOD icon
676
Diodes
DIOD
$4.84B
$2.21K ﹤0.01%
29
+10
+53% +$783
WING icon
677
Wingstop
WING
$3.18B
$2.2K ﹤0.01%
+16
New +$2.36K
TGT icon
678
Target
TGT
$68B
$2.11K ﹤0.01%
14
UNP icon
679
Union Pacific
UNP
$174B
$2.1K ﹤0.01%
10
RBC icon
680
RBC Bearings
RBC
$18B
$2.09K ﹤0.01%
10
+5
+100% +$1.14K
SHAK icon
681
Shake Shack
SHAK
$2.87B
$2.08K ﹤0.01%
50
CLFD icon
682
Clearfield
CLFD
$374M
$2.07K ﹤0.01%
+22
New +$2.32K
COUR icon
683
Coursera
COUR
$1.54B
$2.06K ﹤0.01%
174
+59
+51% +$744
CMC icon
684
Commercial Metals
CMC
$8.31B
$2.03K ﹤0.01%
+42
New +$1.93K
FOR icon
685
Forestar Group
FOR
$1.51B
$1.96K ﹤0.01%
+127
New +$1.68K
XRT icon
686
State Street SPDR S&P Retail ETF
XRT
$654M
$1.95K ﹤0.01%
32
CTVA icon
687
Corteva
CTVA
$51.3B
$1.95K ﹤0.01%
33
BAX icon
688
Baxter International
BAX
$14.2B
$1.9K ﹤0.01%
37
FL
689
DELISTED
Foot Locker
FL
$1.9K ﹤0.01%
50
ADPT icon
690
Adaptive Biotechnologies
ADPT
$3.97B
$1.88K ﹤0.01%
246
+63
+34% +$490
SPSC icon
691
SPS Commerce
SPSC
$2.64B
$1.8K ﹤0.01%
14
+9
+180% +$1.16K
FNDX icon
692
Schwab Fundamental US Large Company Index ETF
FNDX
$27.3B
$1.79K ﹤0.01%
99
VIAV icon
693
Viavi Solutions
VIAV
$9.66B
$1.73K ﹤0.01%
165
MRVL icon
694
Marvell Technology
MRVL
$196B
$1.71K ﹤0.01%
46
TRNS icon
695
Transcat
TRNS
$871M
$1.7K ﹤0.01%
24
+11
+85% +$838
ITCI
696
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.69K ﹤0.01%
32
+16
+100% +$802
LGND icon
697
Ligand Pharmaceuticals
LGND
$6.36B
$1.67K ﹤0.01%
25
-15
-38% -$975
RIG icon
698
Transocean
RIG
$5.82B
$1.6K ﹤0.01%
351
VSHY icon
699
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
$31.6M
$1.49K ﹤0.01%
72
+37
+106% +$762
NVST icon
700
Envista
NVST
$4.52B
$1.45K ﹤0.01%
43
-50
-54% -$1.71K

Similar funds

Raleigh Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Raleigh Capital Management held 915 positions worth $192M, up 12% from $171M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raleigh Capital Management's Q4 2022 filing shows 76 new, 369 increased, 163 reduced and 149 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M. The largest sale was Amgen, an estimated $1.01M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Raleigh Capital Management's largest Q4 2022 buy was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M.
  • Raleigh Capital Management added most to Medtronic in Q4 2022, an estimated $1.02M increase.
  • Raleigh Capital Management's biggest Q4 2022 reduction was Amgen, cutting an estimated $1.01M.
  • Raleigh Capital Management fully exited iShares Core High Dividend ETF in Q4 2022, selling an estimated $454K.
  • Raleigh Capital Management's ten largest holdings make up 20% of its $192M portfolio in Q4 2022.
  • Raleigh Capital Management opened 76 new positions and closed 149 in Q4 2022.
  • Raleigh Capital Management's portfolio value rose 12% quarter-over-quarter to $192M.

Based on Raleigh Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.